Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-07-000130
Filing Date
2007-02-12
Accepted
2007-02-12 15:29:24
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 biovalfd_adlifesci13ga.htm SC 13G/A 105416
  Complete submission text file 0000898432-07-000130.txt   107513
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 1440 DAVEY ROAD WOODRIDGE IL 60517
Business Address (630) 739-6744
Advanced Life Sciences Holdings, Inc. (Subject) CIK: 0001322734 (see all company filings)

EIN.: 300296543
Type: SC 13G/A | Act: 34 | File No.: 005-81504 | Film No.: 07602700
SIC: 2836 Biological Products, (No Diagnostic Substances)